ASR-3001

{{Infobox drug
| drug_name =
| image = 5-MeO-iPALT 2D.svg
| image_class = skin-invert-image
| width = 225px
| caption =
| image2 = 5-MeO-iPALT 3D.png
| image_class2 = bg-transparent
| width2 = 200px

| pronounce =
| tradename =
| Drugs.com =
| MedlinePlus =
| licence_CA =
| licence_EU =
| DailyMedID =
| licence_US =
| pregnancy_AU =
| pregnancy_category =
| dependency_liability =
| addiction_liability =
| routes_of_administration = Oral它是5-MeO-DALT、5-MeO-DiPT和5-MeO-MiPT的结构类似物。

ASR-3001最初于2023年被报道，并于同年授予专利。

参考文献
外部链接

• [https://isomerdesign.com/pihkal/explore/14038 ASR-3001 (5-MeO-ALIPT, 5-MeO-IPALT) - Isomer Design]
• [https://www.prnewswire.com/news-releases/asri-expands-global-reach-with-patent-filings-for-innovative-empathogens-tryptamines-and-phenylalkylamines-302156325.html ASRI Expands Global Reach with Patent Filings for Innovative Empathogens, Tryptamines and Phenylalkylamines (May 28, 2024) - Alexander Shulgin Research Institute - PR Newswire]